Show simple item record

dc.contributor.authorKvivik, Ingeborg
dc.contributor.authorJonsson, Grete
dc.contributor.authorOmdal, Roald
dc.contributor.authorBrede, Cato
dc.date.accessioned2021-08-11T08:44:31Z
dc.date.available2021-08-11T08:44:31Z
dc.date.created2021-06-04T08:56:18Z
dc.date.issued2021
dc.identifier.issn1424-8247
dc.identifier.urihttps://hdl.handle.net/11250/2767317
dc.description.abstractSickness behavior and fatigue are induced by cerebral mechanisms involving inflammatory cytokines. High mobility group box 1 (HMGB1) is an alarmin, and a potential key player in this process. Reliable quantification methods for total HMGB1 and its redox variants must be established in order to clearly understand how it functions. Current methods pose significant challenges due to interference from other plasma proteins and autoantibodies. We aimed to develop an antibody-free sample preparation method followed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) to measure HMGB1 in human plasma. Different methods were applied for the removal of interfering proteins and the enrichment of HMGB1 from spiked human plasma samples. A comparison of methods showed an overall low extraction recovery (<40%), probably due to the stickiness of HMGB1. Reversed-phase liquid chromatography separation of intact proteins in diluted plasma yielded the most promising results. The method produced an even higher degree of HMGB1 purification than that observed with immunoaffinity extraction. Detection sensitivity needs to be further improved for the measurement of HMGB1 in patient samples. Nevertheless, it has been demonstrated that a versatile and fully antibody-free sample preparation method is possible, which could be of great use in further investigations.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleSample Preparation Strategies for Antibody-Free Quantitative Analysis of High Mobility Group Box 1 Proteinen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 by the authorsen_US
dc.source.articlenumber537en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3390/ph14060537
dc.identifier.cristin1913678
dc.source.journalPharmaceuticalsen_US
dc.identifier.citationPharmaceuticals. 2021, 14 (6), 537.en_US
dc.source.volume14en_US
dc.source.issue6en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal